Berlanga Luciana, Lotersztein Vanesa, Aranda Eliseo I, Cerretini Roxana
Centro Nacional de Genética Médica, ANLIS ''Dr Carlos G Malbrán'', Ministerio de Salud de La Nación, Buenos Aires, Argentina.
Breast Cancer Res Treat. 2025 Apr;210(2):385-391. doi: 10.1007/s10549-024-07576-4. Epub 2024 Dec 20.
Among women in Argentina, the most common cancer is breast cancer (BC) with 21,631 new cases and 6436 deaths per year. The ovarian cancer (OC) is fifteenth in frequency. The contribution of cancer-related large genomic rearrangements (LGRs) of the BRCA1/BRCA2 genes and the 1100delC allelic variant in the CHEK2 gene has not yet been widely studied in our population.
LGRs in the BRCA1/BRCA2 genes and the CHEK2 1100delC variant were analyzed using the MLPA technique in 85 unselected Argentinian BC/OC patients.
A pathogenic genetic variant (PV) was found in eleven out of 85 (12,9%) patients, 10 were LGRs in the BRCA1 gene, 9 deletions and one duplication and one the CHEK2 1100delC. Large deletions of exons 1-2 and 15 in BRCA1 gene were recurrent anomalies in our series.
LGRs in the BRCA1 gene contributed significantly to the burden of PVs responsible for the development of BC and OC in our study population. On the other hand, the 1100delC variant in CHEK2 was observed at a very low frequency in our series formed mainly by the Spanish, Italian and Amerindian ethnic groups.
在阿根廷女性中,最常见的癌症是乳腺癌(BC),每年有21631例新发病例和6436例死亡。卵巢癌(OC)的发病频率位列第十五。BRCA1/BRCA2基因的癌症相关大片段基因组重排(LGRs)以及CHEK2基因中的1100delC等位基因变异在我们的人群中尚未得到广泛研究。
使用多重连接依赖探针扩增(MLPA)技术对85例未经选择的阿根廷乳腺癌/卵巢癌患者的BRCA1/BRCA2基因中的LGRs和CHEK2 1100delC变异进行分析。
在85例患者中的11例(12.9%)发现了致病性基因变异(PV),其中10例是BRCA1基因中的LGRs,9例缺失和1例重复,1例是CHEK2 1100delC。BRCA1基因外显子1-2和15的大片段缺失是我们系列中的常见异常情况。
在我们的研究人群中,BRCA1基因中的LGRs对导致乳腺癌和卵巢癌发生的PV负担有显著贡献。另一方面,在我们主要由西班牙、意大利和美洲印第安人种族组成的系列中,CHEK2基因中的1100delC变异观察到频率非常低。